Theriva Biologics

TOVX • AMEX • Stock Fundamentals

Theriva Biologics is a biotechnology company in the healthcare sector trading on AMEX, led by CEO Steven A. Shallcross, with a market cap of $14.1M.

Market Cap$14.1M

Employees22.0

CEOSteven A. Shallcross

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026

Next EarningsAug 12, 2026 · in 2 monthsQ2 2026

Financials

Based on Q1 2026 filing

Common questions about Theriva Biologics

Theriva Biologics (TOVX) has a market capitalization of $14.1M and trades on AMEX.

Theriva Biologics has approximately 22 employees.